Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE)-Reference-Cited by-同舟云学术

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE)

Published:2019-02-20 Issue:8 Volume:21 Page:1032-1041
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Paitazoglou Christina¹,Bergmann Martin W.¹,Vrtovec Bojan²,Chamuleau Steven A.J.³,van Klarenbosch Bas³,Wojakowski Wojtek⁴,Michalewska‐Włudarczyk Aleksandra⁴,Gyöngyösi Mariann⁵,Ekblond Annette⁶,Haack‐Sørensen Mandana⁶,Jaquet Kai⁷,Vrangbæk Karsten⁸,Kastrup Jens⁶,Ciosek Joanna,Dworowy Sebastian,Jadczyk Tomasz,Kozłowski Michal,Nadrowski Pawel,Sagalski Ronja,Schlegel Esther,Schmidt Annette,Sikora Anna,Skiba Dorota,Traxler Denise,Qayyum Abbas Ali,Mathiasen Anders B.,

Affiliation:

1. Department of CardiologyCardiologicum Hamburg Hamburg Germany

2. Advanced Heart Failure and Transplantation CenterUniversity Medical Centre Ljubljana Ljubljana Slovenia

3. Department of Cardiology and Regenerative Medicine CenterUniversity Medical Center Utrecht Utrecht The Netherlands

4. Department of Cardiology and Structural Heart DiseasesMedical University of Silesia Katowice Poland

5. Department of CardiologyMedical University of Vienna Vienna Austria

6. Department of Cardiology and Cardiology Stem Cell CentreRigshospitalet University of Copenhagen Copenhagen Denmark

7. Department of CardiologyAsklepios Klinik St. Georg Hamburg Germany

8. Faculty of Social Sciences and the Faculty of Health SciencesUniversity of Copenhagen Copenhagen Denmark

Funder

Multicentre clinical trial

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1412

Reference30 articles.

1. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis

2. Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

3. A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

4. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)

5. Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study)

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapy as a promising approach for ischemic stroke treatment;Current Research in Pharmacology and Drug Discovery;2024

2. A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications;Cytotherapy;2023-10

3. Heart Failure: Recent Advances and Breakthroughs;Disease-a-Month;2023-09

4. Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements;Journal of Diabetes & Metabolic Disorders;2023-08-29

5. Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study;International Journal of Molecular Sciences;2023-06-26